Georgia Code
Chapter 52 - Terminally Ill Patient’s Right to Try Investigational Drugs, Biological Products, and Devices
§ 31-52-4. Eligibility Criteria

In order for a person to be considered an eligible patient to access an investigational drug, biological product, or device pursuant to this chapter, a physician must document in writing that the person:
History. Code 1981, § 31-52-4 , enacted by Ga. L. 2016, p. 345, § 1/HB 34.

<< Previous
Next >>

Structure Georgia Code

Georgia Code

Title 31 - Health

Chapter 52 - Terminally Ill Patient’s Right to Try Investigational Drugs, Biological Products, and Devices

§ 31-52-1. Short Title

§ 31-52-2. Legislative Findings

§ 31-52-3. Definitions

§ 31-52-4. Eligibility Criteria

§ 31-52-5. Written Informed Consent

§ 31-52-6. Manufacturers Permitted to Make Investigational Drugs, Biological Products, or Devices Available

§ 31-52-7. Coverage Under Health Benefit Plan Permitted but Not Required

§ 31-52-8. Physician Immunity From Sanction for Recommending, Prescribing, or Treating With Investigational Drugs, Biological Products, or Devices

§ 31-52-9. State Prohibited From Blocking Eligible Patient Access

§ 31-52-10. Statutory Construction